A Study With Darapladib to Collect Tolerability Information
NCT00704431
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
2
Enrollment
INDUSTRY
Sponsor class
Conditions
Atherosclerosis
Interventions
DRUG:
SB-480848 (darapladib)
Sponsor
GlaxoSmithKline